OpenFilings

Cidara Therapeutics, Inc.

Form10-K

Report Period2024-12-31

Date Filed2025-03-06

Time Filed16:25:45

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

CIDARA THERAPEUTICS, INC. 2024 FORM 10-K
DESCRIPTION OF THE REGISTRANT'S SECURITIES
NON-EMPLOYEE DIRECTOR COMPENSATION POLICY, AS AMENDED
2020 INDUCEMENT INCENTIVE PLAN, AS AMENDED
EXECUTIVE OFFICERS EMPLOYMENT AGREEMENT, AS AMENDED
INSIDER TRADING POLICY
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934
CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934
CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002
CERTIFICATION OF CFO PURSUANT TO SARBANES-OXLEY ACT OF 2002
Filing on SEC Edgar